31686 | $AMZN 380.75 | clayton | 02/13/2015 1:00:44 PM |
31685 | $UVXY 22.51 | clayton | 02/13/2015 12:49:17 PM |
31684 | $PRAN 1.19 | clayton | 02/13/2015 12:37:19 PM |
31683 | $BID 44.99 | clayton | 02/13/2015 12:34:36 PM |
31682 | $CSNG | clayton | 02/13/2015 12:32:09 PM |
31681 | $RUSL 27.5 | clayton | 02/13/2015 12:29:57 PM |
31680 | $OIH 35.95 | clayton | 02/13/2015 12:22:44 PM |
31679 | $DAL 44.81 | clayton | 02/13/2015 12:15:21 PM |
31677 | $SSO 131.91 | clayton | 02/13/2015 12:07:32 PM |
31676 | $GILD 100.98 | clayton | 02/13/2015 12:00:59 PM |
31675 | $CRIS 2.93 | clayton | 02/13/2015 11:59:01 AM |
31674 | $MO 55.54 | clayton | 02/13/2015 11:58:32 AM |
31673 | $ALK 62.2 | clayton | 02/13/2015 11:56:57 AM |
31672 | $RAD 8.09 | clayton | 02/13/2015 11:53:53 AM |
31671 | $PCLN 1091.95 | clayton | 02/13/2015 11:52:49 AM |
31670 | $HGU.TO | clayton | 02/13/2015 11:49:55 AM |
31669 | $CYTK 7.83 | clayton | 02/13/2015 11:45:04 AM |
31668 | $GS 189.78 | clayton | 02/13/2015 11:40:29 AM |
31667 | $TASR 27.38 | clayton | 02/13/2015 11:36:34 AM |
31665 | $ALK 62.2 | clayton | 02/13/2015 11:33:17 AM |
31664 | $NBG 1.43 | clayton | 02/13/2015 11:20:13 AM |
31663 | $JNJ 98.44 | clayton | 02/13/2015 11:17:50 AM |
31662 | $NFLX 456.73 | clayton | 02/13/2015 11:17:21 AM |
31661 | $DDD 32.41 | clayton | 02/13/2015 11:15:06 AM |
31660 | $EXAS 25.9 | clayton | 02/13/2015 11:14:13 AM |
31659 | $AXP 80.48 | clayton | 02/13/2015 11:11:51 AM |
31658 | $CRIS 2.93 | clayton | 02/13/2015 11:06:42 AM |
31657 | $XIC.TO | clayton | 02/13/2015 10:58:33 AM |
31655 | $SSO 131.91 | clayton | 02/13/2015 10:54:37 AM |
31654 | $AMZN 379.46 | clayton | 02/13/2015 10:51:32 AM |
31653 | $RUSL 25.63 | clayton | 02/13/2015 10:48:50 AM |
31652 | $BAC 16.67 | clayton | 02/13/2015 10:47:34 AM |
31651 | $JNUG 29.76 | clayton | 02/13/2015 10:46:40 AM |
31650 | $SWKS 82.42 | clayton | 02/13/2015 10:39:29 AM |
31649 | $GLD 117.34 | clayton | 02/13/2015 10:15:05 AM |
31648 | $MO 55.54 | clayton | 02/13/2015 10:14:03 AM |
31647 | VRML 2.15 Vermillion Inc $VRML added to my watch | clayton | 02/13/2015 10:13:33 AM |
31646 | PZE Year to date has changed +9.11% percent. | Jake13 | 02/13/2015 10:12:44 AM |
31645 | $CRR 37.62 | clayton | 02/13/2015 10:10:46 AM |
31644 | PUK Year to date has changed +8.71% percent. | Jake13 | 02/13/2015 10:10:23 AM |
31643 | $HK 2.2 | clayton | 02/13/2015 10:09:17 AM |
31642 | $XIV 29.05 | clayton | 02/13/2015 10:01:35 AM |
31641 | $CABN @ .0085! | Estrella | 02/13/2015 9:58:16 AM |
31640 | $XLU 45.87 | clayton | 02/13/2015 9:57:59 AM |
31639 | $CELG 115.72 | clayton | 02/13/2015 9:56:51 AM |
31638 | $CABN @ .0082! | Estrella | 02/13/2015 9:55:47 AM |
31637 | EBSB 12.40 Meridian Interstate Bancorp $EBSB | clayton | 02/13/2015 9:53:05 AM |
31636 | COLM 48.51 Columbia Sportswear Company $COLM | clayton | 02/13/2015 9:51:36 AM |
31635 | SALE 16.28 Retailmenot Inc Stock Charts $SALE | chartguy89 | 02/13/2015 9:48:04 AM |
31634 | PCOM Year to date has changed -7.27% percent. | Jake13 | 02/13/2015 9:40:04 AM |
Recent Articles
- Finetric Media Completes Major Spinout to Enhance Independence
- NVISION Latino Film & Music Festival Finds a New Home in Miami
- Innovative Target Design Enhances Shooting Experience
- Bloomberg Tax Unveils Groundbreaking AI Tools for Tax Research
- Bagnell Law Firm Calls for Sig Sauer to Retract Defamatory Comments
- Guggenheim Securities Welcomes Aerospace Expert Michael Richter
- Deadline Approaching for Grocery Outlet Investors' Lawsuit
- Latest Developments on BioAge Labs, Inc. Securities Lawsuit
- ModivCare Inc. Securities Lawsuit: Investors May Recovery Funds
- Legal Challenge Facing Constellation Brands: What Investors Need to Know
- Join the Class Action: Protect Your Rights with FTAI Aviation
- Legal Alert: Class Action Against TransMedics Group, Inc.
- Join the Class Action: Intellia Therapeutics Investors' Rights
- Important Lawsuit Update for Quantum Computing Inc. Investors
- Oracle Corporation Readies for Impressive Q3 Financial Results
- Class Action Alert for Novo Nordisk A/S Investors Regarding NVO
- Understanding the Legal Landscape for Crocs, Inc. Shareholders
- Worldline Unveils Latest Voting Rights and Share Capital Details
- EssilorLuxottica Publishes Its 2024 Universal Registration Document
- Neumora Therapeutics Investors Must Act by April 2025
- KPMG Confirms Financial Conditions for Bond Categories AL260148
- Growing Opportunities: Tonner Drones Pushes Inhibitor Development
- Cegedim Introduces New Liquidity Contract with Rothschild
- Understanding Robinhood Markets' Recent Options Activity Insights
- Understanding Estee Lauder's Options Activity and Market Trends
- Celebrating the Inspirational Journey of Dr. Cynthia R. Pfeffer
- Diving Deep into AST SpaceMobile's Recent Options Activity
- Investing Wisely in Intellia: Navigating Securities Lawsuits
- Market Movements: Mineralys Therapeutics Sees Major Gains
- Compelling Investigation Reveals Cruelty Towards Lab Rats
- Wingderm® Shines at Key Dermatology Event, Boosting Growth
- US Market Trends Reflect Growing Concerns for Investors
- Chartbeat Expands Its Reach with FatTail Acquisition
- Insight Assurance's New Milestone in AI Governance Certification
- Innovative Portable Side Mirror Solution for Auto Technicians
- Chartbeat Strengthens Media Operations with FatTail Purchase
- Kensington's KHPI Reaches Major Milestone in AUM Growth
- Wingderm® Showcases Cutting-Edge Technologies at AAD Meeting
- Main Event Launches Exciting Spring Break Offer for Families
- Innovative Beef Supply Chain By Rancher's Sustainable Angus Alliance
- Olli Salumeria Unveils Preservative-Free Salamis: A New Era
- Empowering Women in Sailing: Stories of Triumph and Growth
- Navigating Challenges Ahead for Netflix Stock Investors
- Future of the Metal Powder Industry: Growth Trends and Insights
- ServiceNow's Bold Move: What to Expect from the Acquisition
- Kratos Defense & Security Solutions: Analyzing Recent Performance
- Aramis Group's Recent Share Buyback Transactions Explained
- Tevogen Bio Develops Revolutionary T Cell Vaccine Technology
- Investing in Casella Waste Systems: Growth Over 15 Years
- Amgen and Kyowa Kirin Show Promising Eczema Drug Results